APRE Archived Articles
Aprea Therapeutics (APRE): A Promising Oncology Player With a Robust Pipeline
Published on November 30, 2024
Aprea Therapeutics, Inc. (NASDAQ:APRE): Advancing Synthetic Lethality Therapies with Promising Pipeline
Published on September 24, 2024